Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $953.45 | 31 | 97.9% |
| Education | $20.76 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $279.05 | 4 | $0 (2023) |
| Novo Nordisk Inc | $247.28 | 8 | $0 (2024) |
| Amgen Inc. | $99.05 | 4 | $0 (2024) |
| ABBVIE INC. | $98.84 | 4 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $44.50 | 2 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.65 | 2 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $33.13 | 1 | $0 (2023) |
| Horizon Therapeutics plc | $22.88 | 1 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $20.76 | 1 | $0 (2022) |
| Celgene Corporation | $20.54 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.60 | 2 | Amgen Inc. ($31.82) |
| 2023 | $294.07 | 7 | AstraZeneca Pharmaceuticals LP ($123.98) |
| 2022 | $344.32 | 14 | Novo Nordisk Inc ($135.85) |
| 2021 | $284.22 | 9 | AstraZeneca Pharmaceuticals LP ($137.69) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Obesity | ||||||
| 04/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Inflammation | ||||||
| 10/12/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Hematology | ||||||
| 09/21/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Cardiology | ||||||
| 08/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: Inflammation | ||||||
| 08/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $123.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $91.35 | General |
| Category: Obesity | ||||||
| 09/16/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.76 | General |
| Category: NEPHROLOGY | ||||||
| 09/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: PRIMARY CARE | ||||||
| 09/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardio-renal | ||||||
| 09/08/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Bone Health | ||||||
| 05/03/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 04/21/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Cardio-renal | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological), SOLIQUA 100/33 | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Bone Health | ||||||
| 01/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: PRIMARY CARE | ||||||
| 09/28/2021 | AbbVie Inc. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 361 | 2,457 | $346,126 | $201,742 |
| 2022 | 6 | 662 | 4,233 | $702,831 | $300,911 |
| 2021 | 6 | 1,041 | 6,033 | $1.3M | $448,140 |
| 2020 | 5 | 877 | 5,019 | $826,603 | $400,794 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 171 | 2,023 | $274,825 | $156,819 | 57.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 113 | 332 | $54,903 | $37,712 | 68.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 13 | 19 | $3,449 | $2,567 | 74.4% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 16 | 18 | $4,158 | $2,439 | 58.7% |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Facility | 2023 | 36 | 52 | $7,026 | $1,171 | 16.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 12 | 13 | $1,766 | $1,034 | 58.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 170 | 2,113 | $321,276 | $141,197 | 43.9% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 172 | 1,286 | $215,730 | $86,333 | 40.0% |
| 99357 | Extended inpatient or observation hospital service, each additional 30 minutes | Facility | 2022 | 113 | 425 | $78,774 | $29,130 | 37.0% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 106 | 273 | $55,965 | $27,412 | 49.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 80 | 114 | $25,647 | $13,616 | 53.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2022 | 21 | 22 | $5,439 | $3,223 | 59.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 178 | 1,805 | $371,148 | $126,191 | 34.0% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 197 | 1,796 | $367,763 | $124,915 | 34.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 144 | 922 | $158,646 | $61,392 | 38.7% |
| 99357 | Prolonged inpatient or observation hospital service each 30 minutes beyond first hour | Facility | 2021 | 155 | 740 | $152,140 | $51,726 | 34.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 135 | 440 | $112,679 | $45,422 | 40.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 84 | 114 | $31,842 | $14,323 | 45.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 67 | 122 | $31,374 | $12,426 | 39.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 43 | 46 | $13,861 | $5,840 | 42.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2021 | 26 | 32 | $14,189 | $4,798 | 33.8% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Office | 2021 | 12 | 16 | $2,400 | $1,108 | 46.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 239 | 2,713 | $406,950 | $185,431 | 45.6% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 224 | 1,358 | $271,600 | $138,597 | 51.0% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Office | 2020 | 183 | 504 | $75,600 | $35,532 | 47.0% |
About Jasline Jesson
Jasline Jesson is a Family healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1225305774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jasline Jesson has received a total of $974.21 in payments from pharmaceutical and medical device companies, with $51.60 received in 2024. These payments were reported across 32 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($953.45).
As a Medicare-enrolled provider, Jesson has provided services to 2,941 Medicare beneficiaries, totaling 17,742 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Silver Spring, MD
- Active Since 11/29/2011
- Last Updated 11/29/2011
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225305774
Products in Payments
- BREZTRI (Drug) $141.34
- LOKELMA (Drug) $123.98
- Ozempic (Drug) $113.65
- Saxenda (Drug) $91.35
- Otezla (Drug) $63.05
- UBRELVY (Drug) $62.47
- NURTEC ODT (Drug) $56.00
- Kerendia (Drug) $44.50
- CREON (Drug) $36.37
- EVENITY (Biological) $36.00
- OPSUMIT (Drug) $33.13
- PENNSAID (Drug) $22.88
- Rybelsus (Drug) $22.50
- RAYALDEE (Drug) $20.76
- REBLOZYL (Biological) $20.54
- Wegovy (Drug) $19.78
- BELSOMRA (Drug) $18.53
- TOUJEO (Biological) $17.68
- TRINTELLIX (Drug) $15.97
- FASENRA (Biological) $13.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Silver Spring
Ritchell Villaluz, Np-C, NP-C
Family — Payments: $7,400
Mrs. Kelly Mercado, Crnp, CRNP
Family — Payments: $6,646
Elizabeth Bankert, Fnp-C, FNP-C
Family — Payments: $5,857
Mrs. Nicole Mitchell, Crnp, CRNP
Family — Payments: $4,137
Margaret Stubner, Fnp, FNP
Family — Payments: $3,715
Ms. Kathyrn Novak, Np, NP
Family — Payments: $3,519